Levomefolic acid
Names | |
---|---|
IUPAC name
(2S)-2-[ [4-[(2-Amino-5-methyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl) methylamino]benzoyl]amino]pentanedioic acid
|
|
Other names
Alfive
(5-Me-THFA, 5-Me-H4FA), anion: 5-methyltetrahydrofolate (5-Me-THF, 5-Me-H4F), L-methylfolate Metafolin, Extrafolate-S |
|
Identifiers | |
134-35-0 151533-22-1 (calcium salt) |
|
ChemSpider | 392351 |
Jmol 3D model | Interactive image |
KEGG | D09353 |
MeSH | 5-methyltetrahydrofolate |
PubChem | 444412 15341110 (calcium salt) |
UNII | 8S95DH25XC |
|
|
|
|
Properties | |
C20H25N7O6 | |
Molar mass | 459.46 g·mol−1 |
Pharmacology | |
ATC code | B03 |
Legal status |
|
|
|
oral, transdermal, subcutaneous | |
Vapor pressure | {{{value}}} |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
Infobox references | |
Levomefolic acid (INN) (also known as 5-MTHF, L-methylfolate and 5-methyltetrahydrofolate and (6S)-5-methyltetrahydrofolate, and (6S)-5-MTHF) is the primary biologically active form of folic acid used at the cellular level for DNA reproduction, the cysteine cycle and the regulation of homocysteine. It is also the form found in circulation and transported across membranes into tissues and across the blood-brain barrier. In the cell, L-methylfolate is used in the methylation of homocysteine to form methionine and tetrahydrofolate (THF). THF is the immediate acceptor of one carbon units for the synthesis of thymidine-DNA, purines (RNA and DNA) and methionine. The un-methylated form, folic acid (vitamin B9), is a synthetic form of folate, and must undergo enzymatic reduction by methylenetetrahydrofolate reductase (MTHFR) to become biologically active.[1]
It is synthesized in the absorptive cells of the small intestine from polyglutamylated dietary folate. It is a methylated derivative of tetrahydrofolate. Levomefolic acid is generated by MTHFR from 5,10-methylenetetrahydrofolate (MTHF) and used to recycle homocysteine back to methionine by 5-methyltetrahydrofolate-homocysteine methyltransferase (MTR) also known as methionine synthase (MS).[2]
L-methylfolate is water-soluble and primarily excreted via the kidneys. In a study of 21 subjects with coronary artery disease, peak plasma levels were reached in one to three hours following oral or parenteral administration. Peak concentrations were found to be more than seven times higher than folic acid (129 ng/ml vs. 14.1 ng/ml).[3]
Levomefolic acid (and folic acid in turn) has been proposed for treatment of cardiovascular disease[4][5] and advanced cancers such as breast and colorectal cancers[citation needed]. It bypasses several metabolic steps in the body and better binds thymidylate synthase with fDump, a metabolite of the drug fluorouracil.
Levomefolate calcium, a calcium salt of levomefolic acid, is sold under the brand names Metafolin (a registered trademark of Merck KGaA) and Deplin (trademark of Pamlab, LLC).[6] Methyl folate can be bought at online stores or in some chemists though without a prescription.
Metabolism
Legal issues
In March 2012, Merck & Cie of Switzerland, Pamlab LLC (maker of Metanx and Cerefolin, Neevo DHA, and Deplin), and South Alabama Medical Science Foundation (SAMSF) (the plaintiffs) filed a complaint in the United States District Court for the Eastern District of Texas against four defendants - Macoven Pharmaceuticals (owned by Pernix Therapeutics), Gnosis SpA of Italy, Gnosis U.S.A and Gnosis Bioresearch Switzerland. The plaintiffs alleged that the defendants infringed on several of the plaintiffs' patents.[7] The Macoven products named in the suit are: "Vitaciric-B", "ALZ-NAC", "PNV DHA", and l-methylfolate calcium (levomefolate calcium).[8]
In September 2012, the same three plaintiffs filed a complaint requesting that the International Trade Commission begin an investigation of the same four defendants. The complaint states that Gnosis' "Extrafolic-S" and products which are made from it, infringe upon three of their patents: US 5997915, US 6673381, and US 7172778.[9]
See also
- 5,10-Methylenetetrahydrofolate (5,10-CH2-THF, MTHF)
- 5-Methyltetrahydrofolate-homocysteine methyltransferase (MTR)
- Methylenetetrahydrofolate reductase (MTHFR)
- S-Adenosylmethionine (SAMe)
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ http://intetlab.com/site/products/Cerefolin-NAC_package-insert_%204-26-10.pdf
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ The six patents named were US 5997915, US 6011040, US 6254904, US 6673381, US 7674490 and US 7172778.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
External links
- CALCIUM L-5-METHYLTETRAHYDROFOLATE (L-5-MTHF-Ca)
- Lua error in package.lua at line 80: module 'strict' not found.
- Lua error in package.lua at line 80: module 'strict' not found.
- Use dmy dates from February 2013
- Chemical articles with multiple CAS Registry Numbers
- Articles without EBI source
- Pages using collapsible list with both background and text-align in titlestyle
- Vague or ambiguous geographic scope from April 2015
- Articles containing unverified chemical infoboxes
- Articles with unsourced statements from January 2015
- Folates
- Coenzymes
- Patent case law